当前位置:首页 - 行情中心 - 海昇药业(920656) - 财务分析

海昇药业

(920656)

  

流通市值:5.65亿  总市值:17.46亿
流通股本:3237.63万   总股本:1.00亿

海昇药业(920656)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.49亿元,每股收益0.49元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益68269.87万元,未分配利润21576.55万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产70571.28万元,负债2301.40万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入163,844,572.3100,845,726.9441,982,766.72166,209,055.55
营业总成本111,159,132.0368,348,075.928,758,458.48117,608,153.68
其他经营收益
营业利润56,662,633.7234,964,001.4715,231,600.658,322,561.67
利润总额56,681,204.9834,983,551.4715,235,600.658,353,901.5
净利润49,047,356.730,325,906.9813,260,903.8550,750,223.4
每股收益
其他综合收益----
综合收益总额49,047,356.730,325,906.9813,260,903.8550,750,223.4
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计488,806,422.01485,764,554.08503,903,032.22505,518,425.59
非流动资产:
非流动资产合计216,906,334.3204,564,971.51199,823,313.96197,693,541.83
资产总计705,712,756.31690,329,525.59703,726,346.18703,211,967.42
流动负债:
流动负债合计17,232,710.1426,496,923.3937,217,924.8750,220,000.03
非流动负债:
非流动负债合计5,781,310.25196,550.56274,074.2351,597.84
负债合计23,014,020.3926,693,473.9537,491,999.0750,571,597.87
所有者权益(或股东权益):
归属于母公司股东权益合计682,698,735.92663,636,051.64666,234,347.11652,640,369.55
股东权益合计682,698,735.92663,636,051.64666,234,347.11652,640,369.55
负债和股东权益合计705,712,756.31690,329,525.59703,726,346.18703,211,967.42
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计99,635,395.4148,679,002.726,410,327.58138,833,090.89
经营活动现金流出小计80,705,498.5452,160,096.2727,461,343.9114,179,903.18
经营活动产生的现金流量净额18,929,896.87-3,481,093.57-1,051,016.3224,653,187.71
投资活动产生的现金流量:
投资活动现金流入小计1,834,111,195.971,638,713,798.711,049,973,001.461,835,427,691.2
投资活动现金流出小计2,202,265,115.091,798,164,144.721,126,860,216.071,854,299,947.16
投资活动产生的现金流量净额-368,153,919.12-159,450,346.01-76,887,214.61-18,872,255.96
筹资活动产生的现金流量:
筹资活动现金流入小计---386,848,100
筹资活动现金流出小计39,698,10029,798,100-46,300,600
筹资活动产生的现金流量净额-39,698,100-29,798,100-340,547,500
汇率变动对现金及现金等价物的影响-36,256.69104,897.98141,1001,225,349.33
现金及现金等价物净增加额-388,958,378.94-192,624,641.6-77,797,130.93347,553,781.08
期末现金及现金等价物余额57,685,701.55254,019,438.89369,056,014.58446,644,080.49
补充资料:
现金及现金等价物的净增加额--192,624,641.6-347,553,781.08
TOP↑